Nicholas Piramal Q2 net up 86%
By siliconindia   |   Thursday, 24 October 2002, 19:30 IST
Printer Print Email Email
Nicholas Piramal, one of India's largest pharmaceutical companies has posted a net profit of Rs 261.50 million for the quarter ended September 30, 2002.

BANGALORE: The company had posted a net profit of Rs 140.80 million in the quarter ended September 30, 2001. Total Income has increased from Rs 2522.40 million in the quarter ended September 30, 2001 to Rs 2697.70 million in the quarter ended September 30, 2002. The company also announced a change in the management structure with S Ramadorai coming on board as a director. The company also announced that Dr Swati A Piramal has been re-appointed as Director in Wholetime employment of the company (designated as Director Alliances & Communications) for a period of five years with effect from November 19, 2002 subject to approval of the shareholders, which would be obtained at the next AGM of the company.